Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunotherapy
Pharma
Nature retracts provocative PD-1 time-of-day study
The Nature Medicine editors lost confidence in the viral study “due to the amount and nature of the problems identified,” a retraction note shows.
Angus Liu
Jun 24, 2026 11:00am
AZ's Imfinzi, Imjudo combo polishes case in early liver cancer
Jun 1, 2026 8:24am
AZ's Imfinzi bags perioperative OK in early-stage stomach cancer
Nov 25, 2025 4:55pm
Amgen gets some relief in Blincyto patent feud with Lindis
Aug 15, 2025 10:13am
FDA limits Keytruda, Opdivo uses in stomach cancer
Jun 9, 2025 10:50am
ASCO: AZ looks to bring immunotherapy to early stomach cancer
Jun 1, 2025 8:00am
